MECANISMOS DE SEÑALIZACIÓN EN ENFERMEDADES CARDIOVASCULARES Y OTRAS PATOLOGÍAS: DE LA INVESTIGACIÓN BÁSICA A LA CLÍNICA
Hospital Arnau de Vilanova
Valencia, EspañaPublicaciones en colaboración con investigadores/as de Hospital Arnau de Vilanova (6)
2023
-
Key Genes of the Immune System and Predisposition to Acquired Hemophilia A: Evidence from a Spanish Cohort of 49 Patients Using Next-Generation Sequencing
International Journal of Molecular Sciences, Vol. 24, Núm. 22
2020
-
Reducing residual thrombotic risk in patients with peripheral artery disease: Impact of the COMPASS trial
Drugs in Context, Vol. 9
-
Residual risk reduction opportunities in patients with chronic coronary syndrome. Role of dual pathway inhibition
Expert Review of Clinical Pharmacology, Vol. 13, Núm. 7, pp. 695-706
2019
-
Role of rivaroxaban in the prevention of atherosclerotic events
Expert Review of Clinical Pharmacology, Vol. 12, Núm. 8, pp. 771-780
2013
-
Characterization and prognostic implication of 17 chromosome abnormalities in myelodysplastic syndrome
Leukemia Research, Vol. 37, Núm. 7, pp. 769-776
2011
-
Darbepoetin alfa for anemia in patients with low or intermediate-1 risk myelodysplastic syndromes and positive predictive factors of response
Current Medical Research and Opinion, Vol. 27, Núm. 5, pp. 951-960